Ivor Royston - Net Worth and Insider Trading
Ivor Royston Net Worth
The estimated net worth of Ivor Royston is at least $15 Million dollars as of 2024-11-06. Ivor Royston is the Director of Syndax Pharmaceuticals Inc and owns about 750,545 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $15 Million. Ivor Royston is the CEO & President of Viracta Therapeutics Inc and owns about 631,369 shares of Viracta Therapeutics Inc (VIRX) stock worth over $123,748. Ivor Royston is also the Director of Biocept Inc and owns about 19 shares of Biocept Inc (BIOCQ) stock worth over $0. Details can be seen in Ivor Royston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ivor Royston has not made any transactions after 2022-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ivor Royston
Ivor Royston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ivor Royston owns 4 companies in total, including Biocept Inc (BIOCQ) , Syndax Pharmaceuticals Inc (SNDX) , and VIA Pharmaceuticals Inc (VIAP) among others .
Click here to see the complete history of Ivor Royston’s form 4 insider trades.
Insider Ownership Summary of Ivor Royston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BIOCQ | Biocept Inc | 2015-03-16 | director |
| SNDX | Syndax Pharmaceuticals Inc | 2016-03-08 | director |
| VIAP | VIA Pharmaceuticals Inc | 2006-05-11 | director |
 | | 2022-08-26 | director & CEO & President |
Ivor Royston Latest Holdings Summary
Ivor Royston currently owns a total of 3 stocks. Among these stocks, Ivor Royston owns 750,545 shares of Syndax Pharmaceuticals Inc (SNDX) as of March 8, 2016, with a value of $15 Million and a weighting of 99.17%. Ivor Royston owns 631,369 shares of Viracta Therapeutics Inc (VIRX) as of August 26, 2022, with a value of $123,748 and a weighting of 0.83%. Ivor Royston also owns 19 shares of Biocept Inc (BIOCQ) as of March 16, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Ivor Royston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2016-03-08 | 750,545 | 19.69 | 14,778,231 |
| VIRX | Viracta Therapeutics Inc | 2022-08-26 | 631,369 | 0.20 | 123,748 |
| BIOCQ | Biocept Inc | 2015-03-16 | 19 | 0.00 | 0 |
Holding Weightings of Ivor Royston
Ivor Royston Form 4 Trading Tracker
According to the SEC Form 4 filings, Ivor Royston has made a total of 0 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years. The most-recent trade in Syndax Pharmaceuticals Inc is the acquisition of 150,000 shares on March 8, 2016, which cost Ivor Royston around $2 Million.
According to the SEC Form 4 filings, Ivor Royston has made a total of 5 transactions in Viracta Therapeutics Inc (VIRX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Viracta Therapeutics Inc is the sale of 13,379 shares on August 26, 2022, which brought Ivor Royston around $53,650.
According to the SEC Form 4 filings, Ivor Royston has made a total of 0 transactions in Biocept Inc (BIOCQ) over the past 5 years. The most-recent trade in Biocept Inc is the acquisition of 6 shares on March 16, 2015, which cost Ivor Royston around $49,643.
Insider Trading History of Ivor Royston
- 1
Ivor Royston Trading Performance
GuruFocus tracks the stock performance after each of Ivor Royston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ivor Royston is -6.54%. GuruFocus also compares Ivor Royston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ivor Royston within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ivor Royston's insider trading performs compared to the benchmark.
Performance of Ivor Royston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -10.18 | | | | | |
| Relative Return to S&P 500(%) | -11.91 | | | | | |
Ivor Royston Ownership Network
Ownership Network List of Ivor Royston
Ownership Network Relation of Ivor Royston
Ivor Royston Owned Company Details
What does Biocept Inc do?
Who are the key executives at Biocept Inc?
Ivor Royston is the director of Biocept Inc. Other key executives at Biocept Inc include VP & Controller Robert Walsh , Chief Operations Officer Philippe Marchand , and Sr. V.P. & General Counsel Darrell Taylor .
Biocept Inc (BIOCQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biocept Inc (BIOCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biocept Inc (BIOCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biocept Inc (BIOCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biocept Inc Insider Transactions
Ivor Royston Mailing Address
Above is the net worth, insider trading, and ownership report for Ivor Royston. You might contact Ivor Royston via mailing address: 4401 Wilshire Blvd., Suite 200, Los Angeles Ca 90010.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
